Contract DE17
Amerisourcebergen Drug Corp · Department Of Defense · January 9, 2002
Amerisourcebergen Drug Corp was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on January 9, 2002 for $10.81 million of work in medicinal and botanical manufacturing. Performance is in Chesterbrook, PA. This is a task or delivery order issued under parent IDIQ SPE2DX15D3303. It was awarded under full and open competition. The contract has been modified 123 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 1, 2017.
Contract details
- PIID
- DE17
- Parent IDIQ
- SPE2DX15D3303
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chesterbrook, PA
- First action
- January 9, 2002
- Latest action
- September 1, 2017
Description
4539192857!TRICARE WEST
Modification timeline
-
September 1, 2017Base award$4.3K
-
August 30, 2017Base award4539163513!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$3.3K
-
August 30, 2017Base award4539171194!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$1.3K
-
August 21, 2017Base award4539042148!TRBO REGION 3$602
-
August 16, 2017Base award4539001688!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$285
-
June 28, 2017Base award4538482077!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$105
-
June 24, 2017Base award4538452016!TRICARE WEST$2.8K
-
June 23, 2017Base award4538446599!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$269
-
June 8, 2017Base award4538287602!TRICARE WEST$25
-
April 5, 2017Base award4537579698!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$454
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract DE17?
Contract DE17 is a federal contract awarded to Amerisourcebergen Drug Corp by Department Of Defense on January 9, 2002 for $10.81 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 123 times since the base award.
Who won contract DE17?
Amerisourcebergen Drug Corp won contract DE17 from Department Of Defense.
How much is contract DE17 worth?
Contract DE17 has obligated $10.81 million to date.